WallStreetZenWallStreetZen

NASDAQ: NAGE
Niagen Bioscience Inc Stock Ownership - Who owns Niagen Bioscience?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Niagen Bioscience Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert N. FriedChief Executive Officer2025-04-0966,667$3.30
$220.00kBuy
Carlos Luis LopezSVP General Counsel2025-03-07273$7.86
$2.15kBuy
Frank L. Jaksch Jr.Director2024-12-1350,001$3.66
$183.00kBuy
Frank L. Jaksch Jr.Director2024-12-1337,161$6.19
$229.95kSell
Ozan PamirChief Financial Officer2024-11-222,907$7.36
$21.40kBuy

1 of 1

NAGE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NAGE insiders and whales buy or sell their stock.

NAGE Shareholders

What type of owners hold Niagen Bioscience Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hoi Shuen Solina Holly Chau32.19%25,672,139$253.64MInsider
Barry C. Honig26.51%21,143,044$208.89MInsider
Champion River Ventures Ltd24.26%19,349,652$191.17MInsider
Michael Brauser19.08%15,219,914$150.37MInsider
Frank L. Jaksch Jr.17.88%14,260,386$140.89MInsider
Phillip Md Et Al Frost15.80%12,602,939$124.52MInsider
Sheep Flp Black7.81%6,225,155$61.50MInsider
Tricia A. Jaksch7.81%6,225,155$61.50MInsider
Margie Chassman5.53%4,408,640$43.56MInsider
Vanguard Group Inc4.92%3,924,567$38.77MInstitution

1 of 3

NAGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NAGE17.10%82.90%Net Buying
DAWN56.89%43.11%Net SellingNet Selling
VIR67.06%32.94%Net SellingNet Selling
GYRE2.05%97.95%Net Buying
DNTH53.74%46.26%
View Top Biotech Stocks

Niagen Bioscience Stock Ownership FAQ

Who owns Niagen Bioscience?

Niagen Bioscience (NASDAQ: NAGE) is owned by 36.37% institutional shareholders, 176.33% Niagen Bioscience insiders, and 0.00% retail investors. Hoi Shuen Solina Holly Chau is the largest individual Niagen Bioscience shareholder, owning 25.67M shares representing 32.19% of the company. Hoi Shuen Solina Holly Chau's Niagen Bioscience shares are currently valued at $248.25M.

If you're new to stock investing, here's how to buy Niagen Bioscience stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.